It's no secret-the center of gravity for the pharmaceutical industry is shifting to Asia, led by the two developing nations of China and India.
India and China share many similarities as possible partners to Western biopharmaceutical companies & future fast-rising end-markets for new drug sales.
But look deep down and you’ll see two very different areas of possible opportunities. China and India have vastly Different Cultures, Demographics, Business Best Practices etc that NOT ONLY PRESENT CHALLENGES BUT COULD MEAN SUCCESSFUL OR FAILED business ventures.. If you are an SME (Small/Medium Enterprise in Life sciences)- the CHALLENGES BECOME ALMOST IMPOSSIBLE TO Surmount!
DOING YOUR HOMEWORK IS MUST BEFORE DOING BUSINESS in CHINA AND INDIA!
Let FDASmart Inc ASSIST !
We are a New York-USA based company with offices in India and soon an RO office in China.
To see how FDASmart Can Assist your bio-pharmaceutical ventures in India, please see: www.fdasmart.com/emerging.pdf
Opportunities in the East not with-standing, the West needs to PLAN for by analyzing the complex and not-so-obvious ways global trends interact in their industries.